P-gp activation in tumors diminishes accumulation of chemotherapeutic agents inside the cells and prevents it from reaching minimum effective level finally leading to the development of resistance to many currently available anti-cancer drugs, such as paclitaxel and docetaxel [17]. This evidence concerns the gene PGP and cancer.